# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-015669
Filing Date
2023-05-05
Accepted
2023-05-05 17:29:05
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 15933
2 |  | formdefa14a_001.jpg | GRAPHIC | 575757
3 |  | formdefa14a_002.jpg | GRAPHIC | 375235
| Complete submission text file | 0001493152-23-015669.txt |  | 1327132

Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40023 | Film No.: 23895138
SIC: 2834 Pharmaceutical Preparations